CHM
Click for more information
5.56% 1.9¢ chimeric therapeutics limited

Ann: CHM CORE-NK vactosertib Phase 1b study re-opens enrolment, page-5

  1. KrushingIt
    24 Posts.
    lightbulb Created with Sketch. 14
    clock Created with Sketch.
    17/05/24
    06:59
    Post #: 73868805
    This is an FDA approved clinical study that is funded by Case Western. What is not to like about this?

    soon we will have ongoing clinical trials (3 X Phase1B and 1 X 1 Phase 1A). The company represents amazing value….
    CHM Price at posting: 2.2¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 11  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
A1M Swagman shoot proves plentiful for AIC, with Cu beyond 3% close to Eloise
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
ALK Alkane Resources hit 57.2Kozpa gold production through FY24 – and eyeing 70Ktpa in FY26
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
1.9¢ 		Change
0.001(5.56%) 		Mkt cap ! $15.76M
Open High Low Value Volume
1.9¢ 1.9¢ 1.9¢ $12.29K 648.9K

Buyers (Bids)

No. Vol. Price($)
1 12983 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 1432067 5
View Market Depth
Last trade - 10.24am 04/07/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.